<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412020000100004</article-id>
<article-id pub-id-type="doi">10.24245/gom.v88i1.3398</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Metas del tratamiento de pacientes con preeclampsia, previo al parto, en una unidad de cuidados intensivos]]></article-title>
<article-title xml:lang="en"><![CDATA[Goals of prepartum treatment of preeclamptic patients in the intensive care unit]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[Juan Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrera-Escobedo]]></surname>
<given-names><![CDATA[Israel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional La Raza Hospital de Ginecología y Obstetricia 3]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>88</volume>
<numero>1</numero>
<fpage>14</fpage>
<lpage>22</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412020000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412020000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412020000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO: Determinar el porcentaje de alcance de las metas del tratamiento previo al parto de pacientes con preeclampsia internadas en la unidad de cuidados intensivos.  MATERIALES Y MÉTODOS: Estudio de serie de casos, retrospectivo, antes y después, efectuado en pacientes con preeclampsia internadas en la unidad de cuidados intensivos de un hospital de alta especialidad de la Ciudad de México. Se incluyeron pacientes de cualquier edad y paridad, con más de 20 semanas de embarazo y preeclampsia severa. Se compararon los valores antes y después del tratamiento intensivo (medición basal y previa a la finalización del embarazo) considerando nueve metas: 1) presión arterial media &#8804; 95 mmHg; 2) presión venosa central 6 a 10 cm agua; 3) diuresis 1.5 a 2 mL/kg/hora; 4) glucemia menor de 160 mg/dL; 5) presión coloidosmótica plasmática de 24 ± 2 mmHg; 6) pH arterial 7.37 a 7.44; 7) hemoglobina 10 a 14 g/dL; 8) &#8805; 100,000 plaquetas/µL y 9) sin convulsiones. Se consideró meta cumplida la medición anteparto en el límite deseado y meta no cumplida cuando resultó diferente. Se utilizó estadística descriptiva y prueba t de Student.  RESULTADOS: Se estudiaron 100 pacientes con preeclampsia severa. Las metas y porcentaje de cumplimiento fueron: ausencia de convulsiones 100%, glucemia 93%, cuenta plaquetaria 86%, hemoglobina 74%, presión arterial media 39%, diuresis 36%, pH arterial 30%, presión venosa central 24% y presión coloidosmótica plasmática 11%. El promedio general fue 54.77%.  CONCLUSIONES: Solo cuatro metas alcanzaron el porcentaje de cumplimiento &#8805; 70% y cinco con cumplimiento menor de 70%. La evaluación por metas permite identificar las fortalezas y puntos débiles del tratamiento de la preeclampsia en la unidad de cuidados intensivos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE: To know the percentage of goals achieved from the prepartum treatment of preeclamptic pregnant patients in the Intensive Care Unit (ICU).  MATERIALS AND METHODS:  A cross-sectional study included 100 preeclamptic pregnant patients admitted to the ICU of a high-specialty hospital in Mexico City. Values before and after intensive treatment (baseline and antepartum measurement) were compared considering nine goals: 1) mean arterial pressure &#8804;95 mmHg 2) central venous pressure 6 to 10 cm water, 3) diuresis 1.5 to 2 mL/K weight/hour, 4) blood glucose &lt;160 mg / dL, 5) plasma colloid osmotic pressure 24 ± 2 mmHg, 6) pH arterial blood 7.37 to 7.44, 7) hemoglobin 10 to 14 g / dL, 8) platelet count &#8805;100,000 platelets / µL and 9) absent seizures. It was considered as a goal met when the antepartum measurement was in the desired range and goal not met when it was different. Statistical analysis: descriptive statistics and Student´s t-test.  RESULTS:  Goals met absent seizures 100%, blood glucose 93%, platelet count 86%, hemoglobin 74%, mean blood pressure 39%, diuresis 36%, pH arterial blood 30%, central venous pressure 24% and plasma colloid osmotic pressure 11%. The overall average was 54.77%.  CONCLUSIONS:  the goals with percentage of compliance &#8805;70% were seizures, blood glucose, platelet count and hemoglobin. The goals with compliance &lt;70% were mean blood pressure, diuresis, pH arterial blood, central venous pressure and plasma colloid osmotic pressure. The evaluation by goals allows to identify the strengths and weaknesses of the treatment of preeclampsia in the ICU.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Preeclampsia]]></kwd>
<kwd lng="es"><![CDATA[Eclampsia]]></kwd>
<kwd lng="es"><![CDATA[Síndrome HELLP]]></kwd>
<kwd lng="es"><![CDATA[Cuidados críticos en obstetricia]]></kwd>
<kwd lng="es"><![CDATA[Embarazo de alto riesgo]]></kwd>
<kwd lng="en"><![CDATA[Preeclampsia]]></kwd>
<kwd lng="en"><![CDATA[Eclampsia]]></kwd>
<kwd lng="en"><![CDATA[HELLP syndrome]]></kwd>
<kwd lng="en"><![CDATA[Obstetrics critical care]]></kwd>
<kwd lng="en"><![CDATA[High risk pregnancy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phyllis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sibai]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preeclampsia: clinical features and diagnosis]]></article-title>
<source><![CDATA[UpToDate]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>ACOG Practice</collab>
<article-title xml:lang=""><![CDATA[Gestational Hypertension and Preeclampsia]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2019</year>
<volume>133</volume>
<page-range>e1-e25</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eclampsia: a neurological perspective]]></article-title>
<source><![CDATA[J Neurol Sci]]></source>
<year>2008</year>
<volume>271</volume>
<page-range>158-67</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weinstein]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>1982</year>
<volume>142</volume>
<page-range>159-67</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia]]></article-title>
<source><![CDATA[WHO Library Cataloguing-in-Publication Data]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Switzerland ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Magee]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On behalf of the Canadian hypertensive disorders of pregnancy (HDP) working group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy]]></article-title>
<source><![CDATA[Pregnancy Hypertension]]></source>
<year>2014</year>
<volume>4</volume>
<page-range>105-45</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Royal College of Obstetricians and Gynaecologists</collab>
<article-title xml:lang=""><![CDATA[Hypertension in pregnancy: diagnosis and management]]></article-title>
<source><![CDATA[NICE guideline [NG133]]]></source>
<year>2019</year>
<publisher-loc><![CDATA[London UK ]]></publisher-loc>
<publisher-name><![CDATA[National Institute for Health and Clinical Excellence NICE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Prevención, diagnóstico y manejo de la preeclampsia-eclampsia. Lineamiento técnico]]></article-title>
<source><![CDATA[]]></source>
<year>2007</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Centro Nacional de Equidad de Género y Salud Reproductiva de la Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<source><![CDATA[Detección y diagnóstico de enfermedades hipertensivas del embarazo]]></source>
<year>2010</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<source><![CDATA[Guía de Práctica Clínica. Actualización 2017. Prevención, Diagnóstico y Tratamiento de la preeclampsia en el segundo y tercer nivel de atención]]></source>
<year>2017</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Willatts]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of intensive therapy]]></article-title>
<source><![CDATA[Intensive Care Medicine]]></source>
<year>1990</year>
<volume>16</volume>
<page-range>474-6</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lapinsky]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Kruczynski]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Slutsky]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Critical care in the pregnant patient]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>1995</year>
<volume>152</volume>
<page-range>427-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Consejo Nacional de Evaluación de la Política de Desarrollo Social</collab>
<source><![CDATA[Evaluación estratégica sobre mortalidad materna en México 2010: características sociodemográficas que obstaculizan a las mujeres embarazadas su acceso efectivo a instituciones de salud]]></source>
<year>2012</year>
<publisher-loc><![CDATA[México, DF ]]></publisher-loc>
<publisher-name><![CDATA[CONEVAL]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<source><![CDATA[Mortalidad materna. Nota descriptiva]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Control de la tensión arterial media y su correlación con la función renal en pacientes con preeclampsia severa tratadas con tres agentes antihipertensivos orales]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2009</year>
<volume>77</volume>
<page-range>219-26</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olaya-Garay]]></surname>
<given-names><![CDATA[SX]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blood pressure in adolescent patients with pre-eclampsia and eclampsia]]></article-title>
<source><![CDATA[Int J Ginecol Obstet]]></source>
<year>2017</year>
<volume>138</volume>
<page-range>335-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bouvier-Colle MH]]></surname>
<given-names><![CDATA[et. al]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obstetrics patients treated in intensive care units and maternal mortality]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>1996</year>
<volume>65</volume>
<page-range>121-5</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Becerril-Serrano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Líquidos cristaloides sobre la glucemia en preeclampsia severa]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2012</year>
<volume>50</volume>
<page-range>183-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curiel-Balsera]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Prieto-Palomino]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz-Bono]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz de Elvira]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Galeas]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Quesada García]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analysis of maternal morbidity and mortality among patients admitted to obstetric intensive care with severe preeclampsia, eclampsia or HELLP syndrome]]></article-title>
<source><![CDATA[Med Intensiva]]></source>
<year>2011</year>
<volume>35</volume>
<page-range>478-83</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lo]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
<name>
<surname><![CDATA[Mission]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Caughey]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertensive disease of pregnancy and maternal mortality]]></article-title>
<source><![CDATA[Curr Opin Obstet Gynecol]]></source>
<year>2013</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>124-32</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
